Clinical Trials Directory

Trials / Completed

CompletedNCT04410419

Carbohydrate Loading and Diabetes in Colorectal Surgery

In Individuals With Diabetes Undergoing Elective Colorectal Surgery, Is Carbohydrate Loading Preoperatively Safe? A Pilot Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate the feasibility of conducting a large study that would assess the safety of carbohydrate drinks (i.e. juice) prior to elective colorectal surgery in patients with type 2 diabetes. Traditionally, prior to surgeries involving a general anesthetic, patients have been told not to eat or drink anything after midnight due to the risk of aspiration. More recent research have shown that it is safe to have clear fluids up to 2 hours before an operation and this is reflected in the current anesthesia clinical guidelines. Moreover, it has been shown that subjecting patients to a state of starvation causes stress on the body that may lead to complications such as poor wound healing, infections, and delayed return to bowel function. A sugar drink before surgery has been shown to be beneficial and can lead to decreased complication rates and decreased length of stay after surgery. However, it is currently not known if it is safe for patients with type 2 diabetes to have a sugar drink before their surgery since they have trouble processing sugars and a subset of patients with diabetes are at increased risk of aspiration due to delayed stomach emptying. This feasibility study is designed to answer the question of whether a large scale trial can be conducted examining the benefits of a pre-operative sugar drink in patients with type 2 diabetes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPre-operative carbohydrate drinkCarbohydrate drink containing 40g of carbohydrate to be consumed three hours prior to surgery

Timeline

Start date
2018-03-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-06-01
Last updated
2025-08-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04410419. Inclusion in this directory is not an endorsement.